-
Facebook
-
Twitter
-
Google +1
Request a feature- LooksNeat © 2025. All Rights Reserved
- Terms of Service
- Privacy Policy
- Cookies
- Developed by My Guy Solutions, LLC
It was a big year for biotech, writes Juergen Eckhardt, senior vice president of Leaps by Bayer.
A one-time infusion to cure a rare genetic blood disorder. A whole human genome sequenced in just five hours. A child’s incurable cancer sent into remission via gene editing. Just a few years ago, these milestones would have seemed borderline fantastical—the achievements of an era vastly more sophisticated than our own. Yet these are a few of the surprisingly real advances that happened this...